Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology ; volume:7 ; number:4 ; year:2015 ; pages:394-410 ; extent:17
EMBO molecular medicine / European Molecular Biology Organization ; 7, Heft 4 (2015), 394-410 (gesamt 17)
- Creator
-
Devalla, Harsha D.
Schwach, Verena
Ford, John W.
Milnes, James T.
El‐Haou, Said
Jackson, Claire
Gkatzis, Konstantinos
Elliott, David A.
Chuva de Sousa Lopes, Susana M.
Mummery, Christine L.
Verkerk, Arie O.
Passier, Robert
- DOI
-
10.15252/emmm.201404757
- URN
-
urn:nbn:de:101:1-2022120605142724583785
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Devalla, Harsha D.
- Schwach, Verena
- Ford, John W.
- Milnes, James T.
- El‐Haou, Said
- Jackson, Claire
- Gkatzis, Konstantinos
- Elliott, David A.
- Chuva de Sousa Lopes, Susana M.
- Mummery, Christine L.
- Verkerk, Arie O.
- Passier, Robert
Other Objects (12)
Memantine targets glutamate receptors in atrial cardiomyocytes to prevent and treat atrial fibrillation
Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia
The effect of electrical tachypacing on optical action potentials of human atrial cardiomyocytes derived from induced pluripotent stem cells
Biophysical properties of NaV1.5 channels from atrial-like and ventricular-like cardiomyocytes derived from human induced pluripotent stem cells
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Absence of Functional Nav1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes
Atrial fibrillation
Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
Separating atrial near fields and atrial far fields in simulated intra-atrial electrograms
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
Atrial fibrosis progression in patients with Atrial Fibrillation
Left atrial spherical shape change in atrial fibrillation
Memantine targets glutamate receptors in atrial cardiomyocytes to prevent and treat atrial fibrillation
Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia
The effect of electrical tachypacing on optical action potentials of human atrial cardiomyocytes derived from induced pluripotent stem cells
Biophysical properties of NaV1.5 channels from atrial-like and ventricular-like cardiomyocytes derived from human induced pluripotent stem cells
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Absence of Functional Nav1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes
Atrial fibrillation
Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
Separating atrial near fields and atrial far fields in simulated intra-atrial electrograms
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
Atrial fibrosis progression in patients with Atrial Fibrillation
Left atrial spherical shape change in atrial fibrillation
Memantine targets glutamate receptors in atrial cardiomyocytes to prevent and treat atrial fibrillation
Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia
The effect of electrical tachypacing on optical action potentials of human atrial cardiomyocytes derived from induced pluripotent stem cells
Biophysical properties of NaV1.5 channels from atrial-like and ventricular-like cardiomyocytes derived from human induced pluripotent stem cells
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Absence of Functional Nav1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes
Atrial fibrillation
Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
Separating atrial near fields and atrial far fields in simulated intra-atrial electrograms
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
Atrial fibrosis progression in patients with Atrial Fibrillation